Outcome of the EGM held on 12.02.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Drugs Limited held its 1st Extra-Ordinary General Meeting for FY 2025-26 on February 12, 2026, via video conferencing, with 46 members attending. Two special resolutions were passed with overwhelming shareholder approval: (1) issue of equity shares on a preferential basis to promoters and non-promoters for cash, and (2) issue of convertible warrants on a preferential basis to promoters for cash. Both resolutions received 43,60,720 votes in favor (99.9998%) versus just 9 votes against. The promoter group held 39,61,731 shares (about 52.6% of the 75,30,500 total outstanding shares), while public non-institutional shareholders held 35,31,269 shares. Promoters and promoter group were marked as interested parties in both resolutions. The meeting concluded in just 30 minutes.
Shareholders have approved a preferential share and warrant issue, which will dilute existing non-promoter shareholders and strengthen promoter holdings. Specific issue price, quantity, and allotment details are not disclosed in this outcome, so investors should watch for the price, number of shares/warrants, and any lock-in terms in the next corporate filings to gauge actual dilution impact.